What does recognition of rou asset mean?

This represents the non-cash recognition of right-of-use assets under lease accounting standards. It reflects the initial or ongoing capitalization of lease obligations on the balance sheet without an immediate cash outlay. This metric is essential for understanding the company's long-term lease commitments and their impact on the asset base.

NewAmsterdam Pharma Company NAMS Recognition Of Rou Asset

Recognition Of Rou Asset at other companies

BGC Group, Inc.BGC

$34.6M+1,153%

PopularBPOP

$10.4M+42.6%

KadantKAI

$43.24M+18.5%

Nuvation BioNUVB

$967.75K+524%

Plug PowerPLUG

$1.53M-83.7%

Origin BancorpOBK

$35K-93.6%

Other financials

Income statement

See full

Revenue$3.0M+2.1%

Operating income-$58.4M+15.2%

Net income-$48.4M-22.6%

EPS (diluted)-$0.40-17.6%

Balance sheet

See full

Cash & equivalents$457.6M-38.9%

Total debt$23.0K-94.1%

Total equity$665.2M-14.4%

Total assets$732.6M-10.5%

Cash flow

See full

Operating cash flow-$30.6M+16.1%

CapEx$38.0K+138%

Free cash flow-$30.6M+16.0%

Valuation

See full

Market cap$3.67B+63.7%

Profitability

See full

Operating margin-953.6%-3,536pp

Net margin-942.8%-3,477pp

FCF margin-630.1%-6,324pp

Returns & leverage

See full

Return on equity-29.5%-1.8pp

Current ratio9.8×-10.2×

Where this comes from

Reported directly by NewAmsterdam Pharma Company in its filing.

Tagged under the XBRL concept nams:RecognitionOfRouAsset.

The official record: NewAmsterdam Pharma Company’s 10-K, filed February 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about NewAmsterdam Pharma Company's recognition of rou asset.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NewAmsterdam Pharma Company's recognition of rou asset?: NewAmsterdam Pharma Company (NAMS) reported recognition of rou asset of $140.5K in Q4 2024.
What does recognition of rou asset mean?: This represents the non-cash recognition of right-of-use assets under lease accounting standards. It reflects the initial or ongoing capitalization of lease obligations on the balance sheet without an immediate cash outlay. This metric is essential for understanding the company's long-term lease commitments and their impact on the asset base.